Article ID Journal Published Year Pages File Type
8244922 International Journal of Radiation Oncology*Biology*Physics 2006 8 Pages PDF
Abstract
Conclusion: For patients with head-and-neck cancer receiving CRT, intravenous l-alanyl-l-glutamine may be an effective preventive measure to decrease the severity of mucositis.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , , , , , , , ,